Article
Osteocalcin-dependent and -independent metabolic dysregulation in a mouse model of Osteogenesis imperfecta.
Bone research - 16 Jul 2026
Tauer Josephine T, Rauch Frank, Ferron Mathieu, Komarova Svetlana V
Abstract excerpt
Osteogenesis imperfecta (OI) is a rare bone fragility disorder. Previously, in a severe OI mouse model (Col1a1Jrt/+), a sex- and age-dependent metabolic phenotype was observed, correlating with elevated levels of the bone-derived hormone osteocalcin (OCN). This hormone is known to play a crucial role in managing energy metabolism, including glucose regulation and fat mass. In fact, upon high-fat diet (HFD)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
